Company news
Modular Medical, Inc. news in 2024
Modular Medical, Inc.'s news releases, calls and decks from 2024, newest first.
Modular Medical Announces Licensing and Partnership Agreement With Nudge BG
December 18, 2024
Modular Medical Announces Conference Call to Provide Business Update
December 2, 2024
Modular Medical Announces Proposed Public Offering Form 8 K
November 25, 2024
Modular Medical Announces Pricing of $8.2 Million Public Offering
November 20, 2024
Modular Medical Proudly Sponsors the Inaugural Achieving Diabetes Equity in Practice Today (ADEPT) Conference
November 10, 2024
Modular Medical Announces Results from a Successful GLP-1 Proof of Concept Study
November 6, 2024
Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1
September 29, 2024
Modular Medical Announces Issuance of U.S. Patent Covering Key Aspects of Core Pumping Technology
September 17, 2024
Modular Medical Announces Finalization of Protocol for GLP-1 Personalized Metabolic Therapy Study Utilizing the MODD1 Platform
September 10, 2024
Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump
September 3, 2024
Modular Medical Announces Conference Call to Discuss FDA Clearance of the MODD1 Insulin Pump
September 3, 2024
Modular Medical Initiates Transfer of Manufacturing Operations to Phillips Medisize
August 6, 2024
Modular Medical Announces Proof-of-Concept Study for Personalized Metabolic Therapy utilizing the MODD1 Platform
July 14, 2024
Modular Medical Announces Addition to the Russell Microcap(R) Index
June 2, 2024
Modular Medical Announces Steve Gemmell as New Vice President of Engineering
March 25, 2024
Modular Medical Announces Closing of $10 Million Public Offering
February 20, 2024
Modular Medical Announces Pricing of $10 Million Public Offering
February 14, 2024
Modular Medical Announces Issuance of New US Patent
January 23, 2024
Modular Medical Announces 510(k) Submission of MODD1 Insulin Pump
January 18, 2024